Qualitative and quantitative assessment of relative agonist efficacy

Arthur Christopoulos, Esam E. El-Fakahany

Research output: Contribution to journalReview ArticleResearchpeer-review

Abstract

Historically, the ability of a ligand to bind to its receptor and the ability to subsequently activate that receptor have been described as the properties of affinity and intrinsic efficacy, respectively. These properties were originally believed to be independent of one another; both are possessed by ligands classed as 'agonists,' and they have served as the quantitative foundation of the drug and receptor classification process. Although affinity has been interpreted readily in physicochemical terms, equivalent molecular models for efficacy remain elusive. In recent times, there has been a significant paradigm shift in our understanding of the interrelationship between affinity and intrinsic efficacy, particularly on theoretical grounds, yet the actual methods available to measure these parameters remain largely operational. Nevertheless, a number of approaches, based on both functional measurements and radioligand binding studies, are available to quantify agonist efficacy on a relative scale and, to date, these remain the most practical. This commentary discusses the most common of these methods, their advantages and limitations, the dependence of the expression of agonism on the chosen assay system, and the impact of recent biochemical and molecular biological advances on the study of efficacy. Additionally, some of the more contemporary theories regarding the molecular nature of efficacy are briefly discussed, as well as the caveats that always must be borne in mind when any determinations of relative agonist efficacy are made. Copyright (C) 1999 Elsevier Science Inc.

Original languageEnglish
Pages (from-to)735-748
Number of pages14
JournalBiochemical Pharmacology
Volume58
Issue number5
DOIs
Publication statusPublished - 1 Sep 1999
Externally publishedYes

Keywords

  • Affinity
  • Agonism
  • Concentration-response analysis
  • Intrinsic efficacy
  • Radioligand binding
  • Receptor theory

Cite this

@article{31228c5619ad44cdbd2d6e80e35ac626,
title = "Qualitative and quantitative assessment of relative agonist efficacy",
abstract = "Historically, the ability of a ligand to bind to its receptor and the ability to subsequently activate that receptor have been described as the properties of affinity and intrinsic efficacy, respectively. These properties were originally believed to be independent of one another; both are possessed by ligands classed as 'agonists,' and they have served as the quantitative foundation of the drug and receptor classification process. Although affinity has been interpreted readily in physicochemical terms, equivalent molecular models for efficacy remain elusive. In recent times, there has been a significant paradigm shift in our understanding of the interrelationship between affinity and intrinsic efficacy, particularly on theoretical grounds, yet the actual methods available to measure these parameters remain largely operational. Nevertheless, a number of approaches, based on both functional measurements and radioligand binding studies, are available to quantify agonist efficacy on a relative scale and, to date, these remain the most practical. This commentary discusses the most common of these methods, their advantages and limitations, the dependence of the expression of agonism on the chosen assay system, and the impact of recent biochemical and molecular biological advances on the study of efficacy. Additionally, some of the more contemporary theories regarding the molecular nature of efficacy are briefly discussed, as well as the caveats that always must be borne in mind when any determinations of relative agonist efficacy are made. Copyright (C) 1999 Elsevier Science Inc.",
keywords = "Affinity, Agonism, Concentration-response analysis, Intrinsic efficacy, Radioligand binding, Receptor theory",
author = "Arthur Christopoulos and El-Fakahany, {Esam E.}",
year = "1999",
month = "9",
day = "1",
doi = "10.1016/S0006-2952(99)00087-8",
language = "English",
volume = "58",
pages = "735--748",
journal = "Biochemical Pharmacology",
issn = "0006-2952",
publisher = "Elsevier",
number = "5",

}

Qualitative and quantitative assessment of relative agonist efficacy. / Christopoulos, Arthur; El-Fakahany, Esam E.

In: Biochemical Pharmacology, Vol. 58, No. 5, 01.09.1999, p. 735-748.

Research output: Contribution to journalReview ArticleResearchpeer-review

TY - JOUR

T1 - Qualitative and quantitative assessment of relative agonist efficacy

AU - Christopoulos, Arthur

AU - El-Fakahany, Esam E.

PY - 1999/9/1

Y1 - 1999/9/1

N2 - Historically, the ability of a ligand to bind to its receptor and the ability to subsequently activate that receptor have been described as the properties of affinity and intrinsic efficacy, respectively. These properties were originally believed to be independent of one another; both are possessed by ligands classed as 'agonists,' and they have served as the quantitative foundation of the drug and receptor classification process. Although affinity has been interpreted readily in physicochemical terms, equivalent molecular models for efficacy remain elusive. In recent times, there has been a significant paradigm shift in our understanding of the interrelationship between affinity and intrinsic efficacy, particularly on theoretical grounds, yet the actual methods available to measure these parameters remain largely operational. Nevertheless, a number of approaches, based on both functional measurements and radioligand binding studies, are available to quantify agonist efficacy on a relative scale and, to date, these remain the most practical. This commentary discusses the most common of these methods, their advantages and limitations, the dependence of the expression of agonism on the chosen assay system, and the impact of recent biochemical and molecular biological advances on the study of efficacy. Additionally, some of the more contemporary theories regarding the molecular nature of efficacy are briefly discussed, as well as the caveats that always must be borne in mind when any determinations of relative agonist efficacy are made. Copyright (C) 1999 Elsevier Science Inc.

AB - Historically, the ability of a ligand to bind to its receptor and the ability to subsequently activate that receptor have been described as the properties of affinity and intrinsic efficacy, respectively. These properties were originally believed to be independent of one another; both are possessed by ligands classed as 'agonists,' and they have served as the quantitative foundation of the drug and receptor classification process. Although affinity has been interpreted readily in physicochemical terms, equivalent molecular models for efficacy remain elusive. In recent times, there has been a significant paradigm shift in our understanding of the interrelationship between affinity and intrinsic efficacy, particularly on theoretical grounds, yet the actual methods available to measure these parameters remain largely operational. Nevertheless, a number of approaches, based on both functional measurements and radioligand binding studies, are available to quantify agonist efficacy on a relative scale and, to date, these remain the most practical. This commentary discusses the most common of these methods, their advantages and limitations, the dependence of the expression of agonism on the chosen assay system, and the impact of recent biochemical and molecular biological advances on the study of efficacy. Additionally, some of the more contemporary theories regarding the molecular nature of efficacy are briefly discussed, as well as the caveats that always must be borne in mind when any determinations of relative agonist efficacy are made. Copyright (C) 1999 Elsevier Science Inc.

KW - Affinity

KW - Agonism

KW - Concentration-response analysis

KW - Intrinsic efficacy

KW - Radioligand binding

KW - Receptor theory

UR - http://www.scopus.com/inward/record.url?scp=0032777107&partnerID=8YFLogxK

U2 - 10.1016/S0006-2952(99)00087-8

DO - 10.1016/S0006-2952(99)00087-8

M3 - Review Article

VL - 58

SP - 735

EP - 748

JO - Biochemical Pharmacology

JF - Biochemical Pharmacology

SN - 0006-2952

IS - 5

ER -